Loading...

Ligand Pharmaceuticals, Inc.

LGNXZ•PNK
Healthcare
Medical - Pharmaceuticals
$0.002
$0.00(0.00%)
U.S. Market is Open • 13:10

Ligand Pharmaceuticals, Inc. (LGNXZ) Stock Overview

Explore Ligand Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap31.9K
P/E Ratio0.00
EPS (TTM)N/A
ROE0.14%
Fundamental Analysis

AI Price Forecasts

1 Month$0.01
3 Months$0.00
1 Year Target$0.00

LGNXZ Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Ligand Pharmaceuticals, Inc. (LGNXZ) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 42.08, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 0.00 and a market capitalization of 31.9K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
-28.89%
3-Month Change
-23.81%
6-Month Change
33.33%
Year-to-Date (YTD) Change
33.33%
1-Year Change
23.08%
3-Year Change
-62.57%
5-Year Change
-89.54%
All-Time (Max) Change
-97.71%

Contact Information

http://www.ligand.com
858 550 7500
555 Heritage Drive, Jupiter, DE, 33458

Company Facts

68 Employees
IPO DateNov 1, 2022
CountryUS
Actively Trading

Frequently Asked Questions